<?xml version="1.0" encoding="UTF-8"?>

<CodeSystem xmlns="http://hl7.org/fhir">
  <id value="TreatmentRegimen"/>
  <text>
    <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: CodeSystem TreatmentRegimen</b></p><a name="TreatmentRegimen"> </a><a name="hcTreatmentRegimen"> </a><a name="TreatmentRegimen-en-US"> </a><p>This case-insensitive code system <code>https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style="white-space:nowrap">toplusfem<a name="TreatmentRegimen-toplusfem"> </a></td><td>2+5 eller lign, eks. CT</td><td>2+5 eller lign, eks. CT</td></tr><tr><td style="white-space:nowrap">aida<a name="TreatmentRegimen-aida"> </a></td><td>AIDA</td><td>AIDA</td></tr><tr><td style="white-space:nowrap">all_ved<a name="TreatmentRegimen-all_ved"> </a></td><td>ALL vedligehold</td><td>ALL vedligehold</td></tr><tr><td style="white-space:nowrap">atoatra<a name="TreatmentRegimen-atoatra"> </a></td><td>ATO+ATRA</td><td>ATO+ATRA</td></tr><tr><td style="white-space:nowrap">azacitidinmono<a name="TreatmentRegimen-azacitidinmono"> </a></td><td>Azacitidin monoterapi</td><td>Azacitidin monoterapi</td></tr><tr><td style="white-space:nowrap">azacitidinvene<a name="TreatmentRegimen-azacitidinvene"> </a></td><td>Azacitidin-venetoclax</td><td>Azacitidin-venetoclax</td></tr><tr><td style="white-space:nowrap">hydrea<a name="TreatmentRegimen-hydrea"> </a></td><td>Hydrea</td><td>Hydrea</td></tr><tr><td style="white-space:nowrap">hdara_c<a name="TreatmentRegimen-hdara_c"> </a></td><td>Hd-Ara-c +- supplement</td><td>Hd-Ara-c +- supplement</td></tr><tr><td style="white-space:nowrap">ade<a name="TreatmentRegimen-ade"> </a></td><td>ADE +- supplement</td><td>ADE +- supplement</td></tr><tr><td style="white-space:nowrap">da<a name="TreatmentRegimen-da"> </a></td><td>DA +- supplement</td><td>DA +- supplement</td></tr><tr><td style="white-space:nowrap">da31087<a name="TreatmentRegimen-da31087"> </a></td><td>DA inkl. 3+10, 3+8, 3+7</td><td>DA inkl. 3+10, 3+8, 3+7</td></tr><tr><td style="white-space:nowrap">da31087my<a name="TreatmentRegimen-da31087my"> </a></td><td>DA inkl. 3+10, 3+8, 3+7 + mylotarg</td><td>DA inkl. 3+10, 3+8, 3+7 + mylotarg</td></tr><tr><td style="white-space:nowrap">da31087mi<a name="TreatmentRegimen-da31087mi"> </a></td><td>DA inkl. 3+10, 3+8, 3+7 + midostaurin</td><td>DA inkl. 3+10, 3+8, 3+7 + midostaurin</td></tr><tr><td style="white-space:nowrap">flag<a name="TreatmentRegimen-flag"> </a></td><td>FLAG +- supplement</td><td>FLAG +- supplement</td></tr><tr><td style="white-space:nowrap">flagmito<a name="TreatmentRegimen-flagmito"> </a></td><td>FLAG-Ida eller lign inkl FLAG, Mito-FLAG</td><td>FLAG-Ida eller lign inkl FLAG, Mito-FLAG</td></tr><tr><td style="white-space:nowrap">flagmitovene<a name="TreatmentRegimen-flagmitovene"> </a></td><td>FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax</td><td>FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax</td></tr><tr><td style="white-space:nowrap">gilteritinib<a name="TreatmentRegimen-gilteritinib"> </a></td><td>Gilteritinib</td><td>Gilteritinib</td></tr><tr><td style="white-space:nowrap">idarac<a name="TreatmentRegimen-idarac"> </a></td><td>IdAraC</td><td>IdAraC</td></tr><tr><td style="white-space:nowrap">inotuzumab<a name="TreatmentRegimen-inotuzumab"> </a></td><td>Inotuzumab ozogamicin</td><td>Inotuzumab ozogamicin</td></tr><tr><td style="white-space:nowrap">mace<a name="TreatmentRegimen-mace"> </a></td><td>MACE +- supplement</td><td>MACE +- supplement</td></tr><tr><td style="white-space:nowrap">midac<a name="TreatmentRegimen-midac"> </a></td><td>MidAC</td><td>MidAC</td></tr><tr><td style="white-space:nowrap">midostaurin_ved<a name="TreatmentRegimen-midostaurin_ved"> </a></td><td>Midostaurin vedligehold</td><td>Midostaurin vedligehold</td></tr><tr><td style="white-space:nowrap">ldara<a name="TreatmentRegimen-ldara"> </a></td><td>LdARA-C +- supplement</td><td>LdARA-C +- supplement</td></tr><tr><td style="white-space:nowrap">atra<a name="TreatmentRegimen-atra"> </a></td><td>ATRA</td><td>ATRA</td></tr><tr><td style="white-space:nowrap">apl_mt<a name="TreatmentRegimen-apl_mt"> </a></td><td>APL-vedligeholdsbehandling</td><td>APL-vedligeholdsbehandling</td></tr><tr><td style="white-space:nowrap">azacytidin_supplement<a name="TreatmentRegimen-azacytidin_supplement"> </a></td><td>5-Azacytidin +- supplement</td><td>5-Azacytidin +- supplement</td></tr><tr><td style="white-space:nowrap">blinatumomab<a name="TreatmentRegimen-blinatumomab"> </a></td><td>Blinatumomab</td><td>Blinatumomab</td></tr><tr><td style="white-space:nowrap">vyxeos<a name="TreatmentRegimen-vyxeos"> </a></td><td>Vyxeos +- supplement</td><td>Vyxeos +- supplement</td></tr><tr><td style="white-space:nowrap">nopho_2008<a name="TreatmentRegimen-nopho_2008"> </a></td><td>NOPHO-2008</td><td>NOPHO-2008</td></tr><tr><td style="white-space:nowrap">all_mt<a name="TreatmentRegimen-all_mt"> </a></td><td>ALL vedligeholdelsesbehandling</td><td>ALL vedligeholdelsesbehandling</td></tr><tr><td style="white-space:nowrap">other_ikke<a name="TreatmentRegimen-other_ikke"> </a></td><td>Anden ikke-intensiv</td><td>Anden ikke-intensiv</td></tr><tr><td style="white-space:nowrap">other_eks<a name="TreatmentRegimen-other_eks"> </a></td><td>Anden eksperimentel</td><td>Anden eksperimentel</td></tr><tr><td style="white-space:nowrap">other_semi<a name="TreatmentRegimen-other_semi"> </a></td><td>Anden semiintensiv (f.eks. Plan B)</td><td>Anden semiintensiv (f.eks. Plan B)</td></tr><tr><td style="white-space:nowrap">other_int<a name="TreatmentRegimen-other_int"> </a></td><td>Anden intensiv (f.eks. BISHOP, Plan A)</td><td>Anden intensiv (f.eks. BISHOP, Plan A)</td></tr><tr><td style="white-space:nowrap">hyper_cvad<a name="TreatmentRegimen-hyper_cvad"> </a></td><td>Hyper-CVAD</td><td>Hyper-CVAD</td></tr><tr><td style="white-space:nowrap">alltogether_mt<a name="TreatmentRegimen-alltogether_mt"> </a></td><td>ALLtogether</td><td>ALLtogether</td></tr><tr><td style="white-space:nowrap">experimental<a name="TreatmentRegimen-experimental"> </a></td><td>anden behl incl anden experimentel</td><td>anden behl incl anden experimentel</td></tr></table></div>
  </text>
  <url value="https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen"/>
  <version value="0.2.1"/>
  <name value="TreatmentRegimen"/>
  <title value="Treatment regimen"/>
  <status value="active"/>
  <date value="2022-07-12T00:00:00+02:00"/>
  <publisher value="Sundhedsvæsnets Kvalistetsinstitut with Trifork Digital Health A/S"/>
  <contact>
    <name value="Sundhedsvæsnets Kvalistetsinstitut with Trifork Digital Health A/S"/>
    <telecom>
      <system value="url"/>
      <value value="https://trifork.com"/>
    </telecom>
    <telecom>
      <system value="email"/>
      <value value="rbk@trifork.com"/>
    </telecom>
  </contact>
  <description value="Treatment regimen"/>
  <caseSensitive value="false"/>
  <content value="complete"/>
  <count value="37"/>
  <concept>
    <code value="toplusfem"/>
    <display value="2+5 eller lign, eks. CT"/>
    <definition value="2+5 eller lign, eks. CT"/>
  </concept>
  <concept>
    <code value="aida"/>
    <display value="AIDA"/>
    <definition value="AIDA"/>
  </concept>
  <concept>
    <code value="all_ved"/>
    <display value="ALL vedligehold"/>
    <definition value="ALL vedligehold"/>
  </concept>
  <concept>
    <code value="atoatra"/>
    <display value="ATO+ATRA"/>
    <definition value="ATO+ATRA"/>
  </concept>
  <concept>
    <code value="azacitidinmono"/>
    <display value="Azacitidin monoterapi"/>
    <definition value="Azacitidin monoterapi"/>
  </concept>
  <concept>
    <code value="azacitidinvene"/>
    <display value="Azacitidin-venetoclax"/>
    <definition value="Azacitidin-venetoclax"/>
  </concept>
  <concept>
    <code value="hydrea"/>
    <display value="Hydrea"/>
    <definition value="Hydrea"/>
  </concept>
  <concept>
    <code value="hdara_c"/>
    <display value="Hd-Ara-c +- supplement"/>
    <definition value="Hd-Ara-c +- supplement"/>
  </concept>
  <concept>
    <code value="ade"/>
    <display value="ADE +- supplement"/>
    <definition value="ADE +- supplement"/>
  </concept>
  <concept>
    <code value="da"/>
    <display value="DA +- supplement"/>
    <definition value="DA +- supplement"/>
  </concept>
  <concept>
    <code value="da31087"/>
    <display value="DA inkl. 3+10, 3+8, 3+7"/>
    <definition value="DA inkl. 3+10, 3+8, 3+7"/>
  </concept>
  <concept>
    <code value="da31087my"/>
    <display value="DA inkl. 3+10, 3+8, 3+7 + mylotarg"/>
    <definition value="DA inkl. 3+10, 3+8, 3+7 + mylotarg"/>
  </concept>
  <concept>
    <code value="da31087mi"/>
    <display value="DA inkl. 3+10, 3+8, 3+7 + midostaurin"/>
    <definition value="DA inkl. 3+10, 3+8, 3+7 + midostaurin"/>
  </concept>
  <concept>
    <code value="flag"/>
    <display value="FLAG +- supplement"/>
    <definition value="FLAG +- supplement"/>
  </concept>
  <concept>
    <code value="flagmito"/>
    <display value="FLAG-Ida eller lign inkl FLAG, Mito-FLAG"/>
    <definition value="FLAG-Ida eller lign inkl FLAG, Mito-FLAG"/>
  </concept>
  <concept>
    <code value="flagmitovene"/>
    <display value="FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax"/>
    <definition value="FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax"/>
  </concept>
  <concept>
    <code value="gilteritinib"/>
    <display value="Gilteritinib"/>
    <definition value="Gilteritinib"/>
  </concept>
  <concept>
    <code value="idarac"/>
    <display value="IdAraC"/>
    <definition value="IdAraC"/>
  </concept>
  <concept>
    <code value="inotuzumab"/>
    <display value="Inotuzumab ozogamicin"/>
    <definition value="Inotuzumab ozogamicin"/>
  </concept>
  <concept>
    <code value="mace"/>
    <display value="MACE +- supplement"/>
    <definition value="MACE +- supplement"/>
  </concept>
  <concept>
    <code value="midac"/>
    <display value="MidAC"/>
    <definition value="MidAC"/>
  </concept>
  <concept>
    <code value="midostaurin_ved"/>
    <display value="Midostaurin vedligehold"/>
    <definition value="Midostaurin vedligehold"/>
  </concept>
  <concept>
    <code value="ldara"/>
    <display value="LdARA-C +- supplement"/>
    <definition value="LdARA-C +- supplement"/>
  </concept>
  <concept>
    <code value="atra"/>
    <display value="ATRA"/>
    <definition value="ATRA"/>
  </concept>
  <concept>
    <code value="apl_mt"/>
    <display value="APL-vedligeholdsbehandling"/>
    <definition value="APL-vedligeholdsbehandling"/>
  </concept>
  <concept>
    <code value="azacytidin_supplement"/>
    <display value="5-Azacytidin +- supplement"/>
    <definition value="5-Azacytidin +- supplement"/>
  </concept>
  <concept>
    <code value="blinatumomab"/>
    <display value="Blinatumomab"/>
    <definition value="Blinatumomab"/>
  </concept>
  <concept>
    <code value="vyxeos"/>
    <display value="Vyxeos +- supplement"/>
    <definition value="Vyxeos +- supplement"/>
  </concept>
  <concept>
    <code value="nopho_2008"/>
    <display value="NOPHO-2008"/>
    <definition value="NOPHO-2008"/>
  </concept>
  <concept>
    <code value="all_mt"/>
    <display value="ALL vedligeholdelsesbehandling"/>
    <definition value="ALL vedligeholdelsesbehandling"/>
  </concept>
  <concept>
    <code value="other_ikke"/>
    <display value="Anden ikke-intensiv"/>
    <definition value="Anden ikke-intensiv"/>
  </concept>
  <concept>
    <code value="other_eks"/>
    <display value="Anden eksperimentel"/>
    <definition value="Anden eksperimentel"/>
  </concept>
  <concept>
    <code value="other_semi"/>
    <display value="Anden semiintensiv (f.eks. Plan B)"/>
    <definition value="Anden semiintensiv (f.eks. Plan B)"/>
  </concept>
  <concept>
    <code value="other_int"/>
    <display value="Anden intensiv (f.eks. BISHOP, Plan A)"/>
    <definition value="Anden intensiv (f.eks. BISHOP, Plan A)"/>
  </concept>
  <concept>
    <code value="hyper_cvad"/>
    <display value="Hyper-CVAD"/>
    <definition value="Hyper-CVAD"/>
  </concept>
  <concept>
    <code value="alltogether_mt"/>
    <display value="ALLtogether"/>
    <definition value="ALLtogether"/>
  </concept>
  <concept>
    <code value="experimental"/>
    <display value="anden behl incl anden experimentel"/>
    <definition value="anden behl incl anden experimentel"/>
  </concept>
</CodeSystem>